IMMUNOHISTOCHEMISTRY: ALKD5F3

198 Ratings

Rs 6,048 Rs 4,480

26 % OFF

ALKD5F3 DETECTS ELIGIBILITY FOR TYROSINE KINASE INHIBITOR (TKI) THERAPY PRIMARILY IN INDIVIDUALS WITH PULMONARY ADENOCARCINOMA BY IDENTIFYING ALK FUSION PROTEINS.

Why book with us?

  • Free and On Schedule Sample Collection
  • 24/7 Service
  • Affordable
  • Quick and Accurate Reports

SUBMIT TISSUE IN 10% FORMAL-SALINE OR FORMALIN FIXED PARAFFIN EMBEDDED TISSUE BLOCK. SHIP AT ROOM TEMPERATURE. PROVIDE A COPY OF THE HISTOPATHOLOGY REPORT, SITE OF BIOPSY AND CLINICAL HISTORY.

IHC

REPORT ON 4TH DAY EVENING 7PM

PROVIDE A COPY OF THE HISTOPATHOLOGY REPORT, SITE OF BIOPSY AND CLINICAL HISTORY.

Get a Free Call

To Know about Services Detail or any Enquiry.

book health check